- Home
- INM vs RELI Comparison
INM vs RELI Comparison
Compare INM & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- RELI
- Stock Information
- Founded
- INM 1981
- RELI 2013
- Country
- INM Canada
- RELI United States
- Employees
- INM N/A
- RELI N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- RELI Specialty Insurers
- Sector
- INM Health Care
- RELI Finance
- Exchange
- INM Nasdaq
- RELI Nasdaq
- Market Cap
- INM 3.2M
- RELI 3.5M
- IPO Year
- INM N/A
- RELI N/A
- Fundamental
- Price
- INM $3.05
- RELI $1.81
- Analyst Decision
- INM
- RELI
- Analyst Count
- INM 0
- RELI 0
- Target Price
- INM N/A
- RELI N/A
- AVG Volume (30 Days)
- INM 9.5M
- RELI 3.6M
- Earning Date
- INM 05-12-2025
- RELI 07-24-2025
- Dividend Yield
- INM N/A
- RELI N/A
- EPS Growth
- INM N/A
- RELI N/A
- EPS
- INM N/A
- RELI N/A
- Revenue
- INM $4,920,990.00
- RELI $14,208,143.00
- Revenue This Year
- INM N/A
- RELI N/A
- Revenue Next Year
- INM N/A
- RELI N/A
- P/E Ratio
- INM N/A
- RELI N/A
- Revenue Growth
- INM N/A
- RELI 2.40
- 52 Week Low
- INM $1.72
- RELI $0.97
- 52 Week High
- INM $15.70
- RELI $5.11
- Technical
- Relative Strength Index (RSI)
- INM 51.86
- RELI 52.06
- Support Level
- INM $3.32
- RELI $1.85
- Resistance Level
- INM $5.50
- RELI $2.60
- Average True Range (ATR)
- INM 0.37
- RELI 0.38
- MACD
- INM 0.06
- RELI -0.01
- Stochastic Oscillator
- INM 24.69
- RELI 31.33
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About RELI Reliance Global Group Inc.
Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.